
FDA Releases CRLs for Previous Drug and Biologic Product Applications
The FDA has published an initial batch of 202 complete response letters (CRLs)—many of which were issued in response to applications submitted to the FDA between 2020 and 2024—that were seeking the approval of drugs or biologic products.1 Notably, 32 of …